<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(10)</volume><submitter>Bolis M</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)</funding><journal>Blood cancer journal</journal><pagination>76</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6769013</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients.</pubmed_title><pmcid>PMC6769013</pmcid><funding_grant_id>to Enrico Garattini</funding_grant_id><pubmed_authors>Fratelli M</pubmed_authors><pubmed_authors>Terao M</pubmed_authors><pubmed_authors>Pattini L</pubmed_authors><pubmed_authors>Garattini E</pubmed_authors><pubmed_authors>Bolis M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2025-04-21T23:26:06.523Z</modification><creation>2025-04-05T19:05:29.423Z</creation></dates><accession>S-EPMC6769013</accession><cross_references><pubmed>31570689</pubmed><doi>10.1038/s41408-019-0241-5</doi></cross_references></HashMap>